Zobrazeno 1 - 10
of 214
pro vyhledávání: '"Tobias, Peikert"'
Autor:
Sahar A. Saddoughi, MD, PhD, Chelsea Powell, MD, Gregory R. Stroh, MD, Srinivasan Rajagopalan, PhD, Brian J. Bartholmai, MD, Jennifer M. Boland, MD, Marie Christine Aubry, MD, William S. Harmsen, MS, Shanda H. Blackmon, MD, MPH, Stephen D. Cassivi, MD, Francis C. Nichols, MD, Janani S. Reisenauer, MD, K. Robert Shen, MD, Aaron S. Mansfield, MD, Fabien Maldonado, MD, Tobias Peikert, MD, Dennis A. Wigle, MD, PhD
Publikováno v:
Mayo Clinic Proceedings: Digital Health, Vol 2, Iss 1, Pp 44-52 (2024)
Objective: To investigate whether an artificial intelligence (AI)–based model can predict tumor invasiveness in patients with multifocal lung adenocarcinoma (MFLA). Patients and Methods: Patients with MFLA who underwent surgical resection were enro
Externí odkaz:
https://doaj.org/article/7f005bdf4a234beabb353292c8eae05d
Autor:
Faysal Al-Ghoula, Khushbu Patel, Sam Falde, Srinivasan Rajagopalan, Brian Bartholmai, Fabien Maldonado, Tobias Peikert
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-7 (2023)
Abstract While CT lung cancer screening reduces lung cancer-specific mortality, there are remaining challenges. Radiomic tools promiss to address these challenges, however, they are subject to interobserver variability if semi-automated segmentation
Externí odkaz:
https://doaj.org/article/953ed6a6c8c14a7f8978e8b33580b0c0
Autor:
Paige K Marty, Balaji Pathakumari, Thomas M Cox, Virginia P Van Keulen, Courtney L Erskine, Maleeha Shah, Mounika Vadiyala, Pedro Arias-Sanchez, Snigdha Karnakoti, Kelly M Pennington, Elitza S Theel, Cecilia S Lindestam Arlehamn, Tobias Peikert, Patricio Escalante
Publikováno v:
PLoS ONE, Vol 19, Iss 4, p e0301659 (2024)
Clinical prediction of nontuberculous mycobacteria lung disease (NTM-LD) progression remains challenging. We aimed to evaluate antigen-specific immunoprofiling utilizing flow cytometry (FC) of activation-induced markers (AIM) and IFN-γ enzyme-linked
Externí odkaz:
https://doaj.org/article/d1de496605114f6daec64dbbf47d5485
Autor:
Rafael Paez, Michael N. Kammer, Aneri Balar, Dhairya A. Lakhani, Michael Knight, Dianna Rowe, David Xiao, Brent E. Heideman, Sanja L. Antic, Heidi Chen, Sheau-Chiann Chen, Tobias Peikert, Kim L. Sandler, Bennett A. Landman, Stephen A. Deppen, Eric L. Grogan, Fabien Maldonado
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract A deep learning model (LCP CNN) for the stratification of indeterminate pulmonary nodules (IPNs) demonstrated better discrimination than commonly used clinical prediction models. However, the LCP CNN score is based on a single timepoint that
Externí odkaz:
https://doaj.org/article/7b78666c04264aa586a2c11b09157b75
Autor:
Michael N. Kammer, PhD, Hidetoshi Mori, PhD, Dianna J. Rowe, BS, Sheau-Chiann Chen, PhD, Georgii Vasiukov, PhD, Thomas Atwater, MD, Maria Fernanda Senosain, PhD, Sanja Antic, MD, Yong Zou, MS, Heidi Chen, PhD, Tobias Peikert, MD, Steve Deppen, PhD, Eric L. Grogan, MD, Pierre P. Massion, MD, Steve Dubinett, MD, Marc Lenburg, PhD, Alexander Borowsky, MD, Fabien Maldonado, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 9, Pp 100504- (2023)
Introduction: Lung cancer is the deadliest cancer in the United States and worldwide, and lung adenocarcinoma (LUAD) is the most prevalent histologic subtype in the United States. LUAD exhibits a wide range of aggressiveness and risk of recurrence, b
Externí odkaz:
https://doaj.org/article/965e0718212541d0a561efc2131ac3f6
Autor:
Mitesh J Borad, Giannoula Karagouga, Jun Yin, Stephen Murphy, Paul Baas, James Smadbeck, John Cheville, Alexa McCune, Aaron Mansfield, George Vasmatzis, Aakash P Desai, Farhad Kosari, Maria Disselhorst, Alireza Agahi, Tobias Peikert, Julia Udell, Sarah H Johnson, Janet Schaefer-Klein
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 6 (2023)
Background Immune checkpoint inhibitors (ICIs) are now a first-line treatment option for patients with pleural mesothelioma with the recent approval of ipilimumab and nivolumab. Mesothelioma has a low tumor mutation burden and no robust predictors of
Externí odkaz:
https://doaj.org/article/a6826c67289e41c885adfe1bf7000f0b
Autor:
Heather M. Robison, Cole A. Chapman, Haowen Zhou, Courtney L. Erskine, Elitza Theel, Tobias Peikert, Cecilia S. Lindestam Arlehamn, Alessandro Sette, Colleen Bushell, Michael Welge, Ruoqing Zhu, Ryan C. Bailey, Patricio Escalante
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Accurate detection and risk stratification of latent tuberculosis infection (LTBI) remains a major clinical and public health problem. We hypothesize that multiparameter strategies that probe immune responses to Mycobacterium tuberculosis ca
Externí odkaz:
https://doaj.org/article/ed475f1ab43d45d0815b964dab889d2f
Autor:
Paige K. Marty, Virginia P. Van Keulen, Courtney L. Erskine, Maleeha Shah, Amber Hummel, Michael Stachowitz, Samantha Fatis, Dane Granger, Matthew S. Block, Alí Duarte-García, Kenneth J. Warrington, Elitza S. Theel, Xian Zhou, Hu Zeng, Ulrich Specks, Patricio Escalante, Tobias Peikert
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Humoral vaccine responses are known to be suboptimal in patients receiving B-cell targeted therapy, and little is known about vaccine induced T-cell immunity in these patients. In this study, we characterized humoral and cellular antigen-specific ant
Externí odkaz:
https://doaj.org/article/d90f575f1fbd43b5bd5b27a01dda881f
Autor:
Alvise Berti, Sophie Hillion, Amber M. Hummel, Young Min Son, Nedra Chriti, Tobias Peikert, Eva M. Carmona, Wayel H. Abdulahad, Peter Heeringa, Kristina M. Harris, E. William St. Clair, Paul Brunetta, Fernando C. Fervenza, Carol A. Langford, Cees G.M. Kallenberg, Peter A. Merkel, Paul A. Monach, Philip Seo, Robert F. Spiera, John H. Stone, Guido Grandi, Jie Sun, Jacques-Olivier Pers, Ulrich Specks, Divi Cornec, for the RAVE-ITN Research Group
Publikováno v:
JCI Insight, Vol 6, Iss 22 (2021)
BACKGROUND Little is known about the autoreactive B cells in antineutrophil cytoplasmic antibody–associated (ANCA-associated) vasculitis (AAV). We aimed to investigate tolerance checkpoints of circulating antigen-specific proteinase 3–reactive (P
Externí odkaz:
https://doaj.org/article/17108e393aed484eae0eb4f26d7643a8
Autor:
Alvise Berti, Sophie Hillion, Maximilian F. Konig, Marta Casal Moura, Amber M. Hummel, Eva Carmona, Tobias Peikert, Fernando C. Fervenza, Cees G.M. Kallenberg, Carol A. Langford, Peter A. Merkel, Paul A. Monach, Philip Seo, Robert F. Spiera, Paul Brunetta, E. William St. Clair, Kristina M. Harris, John H. Stone, Guido Grandi, Jacques‐Olivier Pers, Ulrich Specks, Divi Cornec
Publikováno v:
Arthritis & Rheumatology. 75:736-747
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b09bd7ca4c69ee82613e54f0fdec890b
https://doi.org/10.1002/art.42388
https://doi.org/10.1002/art.42388